The global protein A resin market is witnessing a surge in demand due to its ability to bind antibodies. Protein A resin is a recombinant protein used to purify monoclonal antibodies. It is used extensively in biopharmaceuticals, diagnostics, and research laboratories.
Browse in-depth TOC on "Protein A Resin Market”
103 – Tables
42 – Figures
137 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19196962
The increasing demand for monoclonal antibodies for therapeutic and diagnostic applications is expected to drive the growth of the global protein A resin market. Additionally, the growing number of biopharmaceutical companies and the rising demand for protein A resin from research laboratories are key factors driving the growth of the global protein A resin market.
Key Market Players
The prominent players in the global protein A resin market include GE Healthcare (US), Merck Millipore (Germany), Repligen Corporation (US), Thermo Fisher Scientific (US), Tosoh Bioscience (Japan), Purolite Corporation (US), Novasep Holding SAS (France), Agilent Technologies (US), GenScript Biotech Corporation (China), PerkinElmer (US), Bio-Rad Laboratories (US), Orochem (US), Kaneka Corporation (Japan), Abcam (UK), Agarose Bead Technologies (US), Avantor (US), JSR Life Sciences (US), Bio-Works Technologies (Sweden), Amikozen Co. Ltd. (US), and Takara Bio Inc. (Japan).
The global protein A resin market is segmented by end user into biopharmaceuticals, diagnostics, and research laboratories. The biopharmaceuticals segment is expected to hold the largest share of the global protein A resin market, due to the increased demand for monoclonal antibodies for therapeutic and diagnostic applications.
The global protein A resin market is further segmented by region into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to dominate the global protein A resin market, due to the presence of a large number of biopharmaceutical companies in the region.
North America to dominate the market
North America, Europe, Asia Pacific, and the Rest of the World (RoW) are the regions considered for geographic analysis of the global protein A resin market study. North America is expected to account for the largest share of the global market. The large share of North America is attributed to the A strong monoclonal antibody therapeutics market in North America is the key driver for the Recombinant protein A market in the region.
The global protein A resin market is expected to witness a steady growth in the coming years, due to the increasing demand for monoclonal antibodies and the growing number of biopharmaceutical companies. Companies are focusing on developing new products to strengthen their market position and gain a competitive edge.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=19196962
This research report categorizes the protein A ?resin market based on product, type, application, end user, and region.
By Product
- Agarose-based Protein A
- Glass/Silica-based Protein A
- Organic Polymer-based Protein A
By Type
- Recombinant Protein A
- Natural Protein A
By Application
- Antibody Purification
- Immunoprecipitation
By End-User
- Pharmaceutical & Biopharmaceutical Companies
- Academic Research Institutes
- Other End Users
By Region
- North America
- Europe
- Asia Pacific
- RoW
Recent Developments
- Merck Millipore (Germany) opened a new manufacturing and distribution center in India for its Life Science business.
- Repligen Corporation (US) merged with Spectrum Inc. (US), a leader in membrane separation technologies for the pharmaceutical, bioprocess, diagnostic, and research industries. This merger was aimed at accelerating the growth of its filtration business and enhancing its position as a leading developer of single-use and continuous manufacturing technologies for bioprocessing.
- Purolite Life Sciences collaborated with ChromaTan Corporation (US), which provides chromatography solutions. The development increased the production of protein A resins by up to 15 times.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=19196962
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
